A worker prepares a syringe with the Pfizer COVID-19 vaccine at a clinic at the Reading Area Community College in Reading, Pa.
Matt Rourke / AP Photo
A worker prepares a syringe with the Pfizer COVID-19 vaccine at a clinic at the Reading Area Community College in Reading, Pa.
Matt Rourke / AP Photo
(Washington) — Pfizer and BioNTech are officially asking the Biden administration to authorize the use of their COVID-19 vaccine for children ages 5 to 11.
Pfizer tweeted on Thursday that the companies had submitted their formal request for Emergency Use Authorization of the vaccine to the Food and Drug Administration.
“With new cases in children in the U.S. continuing to be at a high level, this submission is an important step in our ongoing effort against #COVID19,” the pharmaceutical giant said.
The submission is the latest development in the push to expand use of the vaccine to younger children, a process being closely watched by many anxious parents as the new school year gets underway.
The Pfizer-BioNTech vaccine has full FDA approval for people ages 16 and older, and those between the ages of 12 and 15 can get the shot under the current emergency use authorization.
Last month Pfizer and BioNTech submitted data to the FDA showing that their vaccine produced a “robust” antibody response in kids from 5-11 and had “favorable” safety outcomes.
A collection of interviews, photos, and music videos, featuring local musicians who have stopped by the WITF performance studio to share a little discussion and sound. Produced by WITF’s Joe Ulrich.